Figure 5.
Overall COVID-19 clinical classification scheme
(A and B) CD4+ T cell responses to spike and CD4RE MPs were measured as percentage of AIM+ (OX40+CD137+) CD4+ T cells and plotted in two dimensions as (A) SFCs per million PBMCs or (B) stimulation index (SI), in order to discriminate the 5 study groups with known COVID-19 status of infection and/or vaccination. I−V−, unexposed and unvaccinated (n = 50); I+V−, infected and non-vaccinated (n = 50); I−V+, non-infected and vaccinated (n = 66); I+V+/V+I+, infected and then vaccinated (I+V+, n = 50) merged with vaccinated and then infected (V+I+, n = 23). Red dotted lines indicate specific cutoffs. Table inserts depict the diagnostic exam results in 4×4 matrix. Sensitivity, specificity, PPV, NPV of all the subjects that participated in this study (n = 239), and overall percentage classified correctly is shown.